Your browser doesn't support javascript.
loading
Cushing's disease: role of preoperative and primary medical therapy.
Castinetti, Frederic.
Afiliação
  • Castinetti F; Department of Endocrinology, Assistance Publique-Hopitaux de Marseille, INSERM, Marseille Medical Genetics, Marmara Institute, French Reference Center for Rare Pituitary Diseases, Endo-European Reference Network and EURACAN European Expert Center on Rare Pituitary Tumors, La Conception Hospital, Aix Marseille University, 147 Boulevard Baille, 13385, Marseille Cedex 05, France. Frederic.castinett@ap-hm.fr.
Pituitary ; 25(5): 737-739, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35780261
Transsphenoidal surgery is the first-line treatment for Cushing's disease. However, some situations may require the use of a primary medical treatment, such as in patients with severe life-threatening hypercortisolism, a situation which can be handled by fast-acting steroidogenesis inhibitors, instead of classical bilateral adrenalectomy. Primary medical treatment could also be considered in patients with non-severe hypercortisolism, but the evidence is far less convincing for its systematic use. The aim of this short review is to explain briefly the different circumstances in which primary medical therapy could be considered, the limits of this approach, and the way in which to initiate and monitor the treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Cushing / Hipersecreção Hipofisária de ACTH / Inibidores da Síntese de Esteroides Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Cushing / Hipersecreção Hipofisária de ACTH / Inibidores da Síntese de Esteroides Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article